Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating faropenem medoxomil for chronic bronchitis was terminated, with no efficacy or safety conclusions provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• Faropenem medoxomil (faropenem medoxomil)

Snippet

Sponsor: Replidyne | Conditions: Chronic Bronchitis | Phase 3 | Status: TERMINATED